Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Quality Index
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Quality Index of 1.48x as of September 2025. Operating cash flow of CN¥174.36 Million exceeds net income of CN¥117.90 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of Wuhan Keqian Biology Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Keqian Biology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Wuhan Keqian Biology Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Wuhan Keqian Biology Co Ltd. For live market cap and the full company financial profile, see Wuhan Keqian Biology Co Ltd (688526) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.03x | CN¥392.68 Million | CN¥381.49 Million | ▼ -24.3% |
| 2023 | 1.36x | CN¥538.03 Million | CN¥395.93 Million | ▲ +31.2% |
| 2022 | 1.04x | CN¥423.71 Million | CN¥409.15 Million | ▲ +11.2% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥570.64 Million | ▲ +4.2% |
| 2020 | 0.89x | CN¥400.14 Million | CN¥447.80 Million | ▲ +40.0% |
| 2019 | 0.64x | CN¥154.89 Million | CN¥242.64 Million | ▼ -29.4% |
| 2018 | 0.90x | CN¥351.83 Million | CN¥388.91 Million | ▼ -14.2% |
| 2017 | 1.05x | CN¥337.61 Million | CN¥320.31 Million | ▼ -11.1% |
| 2016 | 1.19x | CN¥220.69 Million | CN¥186.17 Million | — |